Robert Beasley Joins Chicago Atlantic as Partner, Head of Restructuring
Chicago Atlantic announced the appointment of former FLUENT Cannabis CEO Robert Beasley, as Partner, Head of Restructuring. Beasley will be responsible for supporting the firm’s ongoing commitment to value creation and operational excellence across its portfolio.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250825185390/en/
Robert Beasley has joined Chicago Atlantic as Partner, Head of Restructuring
Beasley is an attorney, entrepreneur, and business executive with a proven track record of leading organizations and shaping policy in highly regulated industries, including the emerging cannabis market. A Florida native, he co-founded the law firm Litvak, Beasley, Wilson & Ball in 2001, where he specialized in commercial, regulatory law and business strategy. He went on to play a pivotal role in shaping Florida’s medical cannabis landscape, actively participating in the legislative and rulemaking processes of the Compassionate Medical Cannabis Act. In 2016, he supported Florida’s Medical Marijuana Legalization Initiative (Amendment 2) and joined the initial Board of Managers for the state’s leading independent cannabis physician clinic group, expanding patient access. The following year, he was appointed to the Board of one of Florida’s first licensed cannabis operators.
Most recently, from 2020 to 2025, Beasley served as CEO of FLUENT Cannabis, a vertically integrated multi-state operator. During his tenure, he expanded the company’s retail footprint, optimized cultivation and production capabilities, strengthened its market position in Florida and led its entry into the New York market. With a career spanning law, policy, and executive leadership, Beasley brings a proven track record of driving growth, advancing patient access, and guiding organizations through complex regulatory landscapes.
“I am excited to join the Chicago Atlantic team with whom I have worked with to great success while in the cannabis space,” said Beasley. “Their team is extremely proficient and approach business relationships with the high level of integrity that aligns with my own personal values."
“We are thrilled to welcome Robert to Chicago Atlantic,” said Tony Cappell, Partner at Chicago Atlantic. “He brings a unique combination of legal, operational, and regulatory expertise and will partner with our investment and leadership teams to guide businesses through transition, enhance performance, and unlock long-term growth opportunities.”
About Chicago Atlantic
Chicago Atlantic is a private markets alternative investment manager focused on industries and companies where demand for capital exceeds traditional supply. The firm’s investment strategies include opportunistic private credit and equity with focuses on loans to esoteric industries, specialty asset-based loans, liquidity solutions and growth and technology finance. Chicago Atlantic has closed over $2.8 billion in credit facilities. Chicago Atlantic’s team of over 95 professionals has offices in Chicago, Miami, New York and London. For more information on Chicago Atlantic’s investment opportunities and financing products, visit chicagoatlantic.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250825185390/en/
Contacts
marketing@chicagoatlantic.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MultiBank Group Completed First $MBG Buyback & Burn, Removing 4.86M Tokens After Record H1 2025 Financial Results.27.8.2025 13:40:00 EEST | Press release
MultiBank Group, the world’s largest financial derivatives institution, has announced the successful execution of its buyback and burn program, permanently removing 4,860,000 $MBG tokens from circulation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250827632341/en/ MultiBank Group Completed First $MBG Buyback & Burn, Removing 4.86M Tokens After Record H1 2025 Financial Results. The milestone follows the Group’s record-breaking financial results, with H1 2025 revenue reaching $209 million and an average daily trading turnover of $36 billion since the Token Generation Event on July 22. The $MBGBuyback and Burn program underscores MultiBank Group’s commitment to rewarding its community while strengthening the long-term fundamentals of the $MBG Utility Token. By reducing supply, the Group is actively driving scarcity and reinforcing token value. The initiative is structured to scale significantly, with up to $58.2 million wor
Ant International, Standard Chartered and Swift Collaborate to Pioneer Bank-to-Wallet Payment Solution Backed by ISO 2002227.8.2025 13:35:00 EEST | Press release
Supported by Swift’s trusted infrastructure, Ant International, a leading global digital payment, digitisation and financial technology provider, and Standard Chartered Bank have launched live production trials for a bank-to-wallet payment solution using the ISO 20022 financial messaging standards. Through Alipay+, the global wallet gateway service under Ant International, the first transactions were completed successfully between a Standard Chartered Bank customer account and a partner e-wallet. Through simplifying global money transfers, the innovative solution leverages the Swift network of over 11,500 financial institutions in more than 200 countries and territories to connect to 1.7 billion user accounts on the 36 global digital wallets in the Alipay+ ecosystem, especially across fast-growing Asian markets. Michael Spiegel, Global Head of Transaction Banking, Standard Chartered said: “We are pleased to be the bank of choice to conceptualise, test and deliver this innovation. It is
Compass Pathways to Participate in Four Investor Conferences in September27.8.2025 13:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in the following September investor conferences: Cantor Global Healthcare Conference – New York, NY: Fireside chat at 1:35 PM EST on September 3, 2025 Morgan Stanley 23rd Annual Global Healthcare Conference – New York, NY: Fireside chat at 10:45 AM EST on September 9, 2025 H.C. Wainwright 27th Annual Global Investment Conference – New York, NY: Fireside chat at 9:00 AM EST on September 9, 2025 TD Cowen’s 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit: Virtual fireside chat at 10:40 AM EST on September 17, 2025 A live audio webcast of these events will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a
From Paris with Love : KARL LAGERFELD’s Fall/Winter 2025 Campaign27.8.2025 13:02:00 EEST | Press release
Paris...meet Paris. KARL LAGERFELD is proud to unveil its Fall/Winter 2025 campaign, From Paris with Love, starring global icon Paris Hilton. Blending her one-of-a-kind charisma with the brand’s unmistakable aesthetic, the campaign playfully unites two cultural forces who have shaped pop culture on their own terms. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250826688190/en/ KARL LAGERFELD Fall Winter 25 Campaign - Paris Hilton - ©Chris Colls Embracing both an elegant and witty visual dialogue between Paris Hilton and the Maison’s Parisian roots, the campaign explores themes of glamour, individuality, and attitude—channeling the irreverent spirit and sharp sophistication that defined Karl Lagerfeld himself. The result is a celebration of authenticity and self-expression, presenting Paris in a fresh, unexpected light and reframing her renowned image through the lens of the brand’s distinctive point of view. The FW25 360 ca
European Commission Approves TEVIMBRA ® as Neoadjuvant/Adjuvant NSCLC Treatment Ahead of Late-Breaking Data Presentation at WCLC 202527.8.2025 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the European Commission (EC) has approved TEVIMBRA (tislelizumab), in combination with platinum-containing chemotherapy as neoadjuvant treatment followed by TEVIMBRA monotherapy as adjuvant treatment, for adult patients with resectable non-small cell lung cancer (NSCLC) at high risk of recurrence. The EC approval is based on results from the Phase 3 RATIONALE-315 trial. The preplanned final analysis of RATIONALE-315 demonstrates that TEVIMBRA, combined with platinum-based chemotherapy before surgery and continued as monotherapy afterward, showed statistically significant and clinically meaningful benefit in overall survival (OS) compared with chemotherapy combined with placebo. Data from this trial will be presented as a Late-Breaking Abstract (#MA04.08)1 at the IASLC 2025 World Conference on Lung Cancer (WCLC) hosted by the International Association for the Study of Lung Cance
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom